APO Research
Talk to an analyst

APO RESEARCH · REPORT

DNA Oligonucleotide Synthesis Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global DNA Oligonucleotide Synthesis Service Market Outlook and Growth Opportunities 2026

12 August 2026201 pages

Choose your research edition.

Industry ResearchDNA Oligonucleotide Synthesis Service Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal DNA Oligonucleotide Synthesis Service Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal DNA Oligonucleotide Synthesis Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DNA Oligonucleotide Synthesis Service Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal DNA Oligonucleotide Synthesis Service Market Analysis and Forecast 2026-2032187 pages · $4,950 USD

Market perspective

The global DNA Oligonucleotide Synthesis Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for DNA Oligonucleotide Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for DNA Oligonucleotide Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DNA Oligonucleotide Synthesis Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the DNA Oligonucleotide Synthesis Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the DNA Oligonucleotide Synthesis Service market include Genewiz, Eurofins Genomics, Gene Oracle, SBS Genetech, Creative Biolabs, Bio Basic, Kaneka Eurogentec SA, AltaBioscience and Synbio Technologies, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global DNA Oligonucleotide Synthesis Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of DNA Oligonucleotide Synthesis Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents DNA Oligonucleotide Synthesis Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global DNA Oligonucleotide Synthesis Service market.

DNA Oligonucleotide Synthesis Service Segment by Company

Genewiz

Eurofins Genomics

Gene Oracle

SBS Genetech

Creative Biolabs

Bio Basic

Kaneka Eurogentec SA

AltaBioscience

Synbio Technologies

TriLink

Azenta Life Science

KareBay Biochem

Creative Biogene

Generi Biotech

Primetech

General Biosystems

GenScript

OriGene

BBI

DNA Oligonucleotide Synthesis Service Segment by Type

Standard Oligonucleotides

Micro-Oligonucleotides

Large-scale Oligonucleotides

Degenerate Primers

Long Oligos Synthesis

DNA Oligonucleotide Synthesis Service Segment by Application

Commercial

Academic Research

DNA Oligonucleotide Synthesis Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global DNA Oligonucleotide Synthesis Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the DNA Oligonucleotide Synthesis Service key companies, revenue, market share, and recent developments.

3. To split the DNA Oligonucleotide Synthesis Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions DNA Oligonucleotide Synthesis Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify DNA Oligonucleotide Synthesis Service significant trends, drivers, influence factors in global and regions.

6. To analyze DNA Oligonucleotide Synthesis Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Oligonucleotide Synthesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DNA Oligonucleotide Synthesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Oligonucleotide Synthesis Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global DNA Oligonucleotide Synthesis Service industry.

Chapter 3: Detailed analysis of DNA Oligonucleotide Synthesis Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of DNA Oligonucleotide Synthesis Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of DNA Oligonucleotide Synthesis Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. DNA Oligonucleotide Synthesis Service Industry Trends Table 2. DNA Oligonucleotide Synthesis Service Industry Drivers Table 3. DNA Oligonucleotide Synthesis Service Industry Opportunities and Challenges Table 4. DNA Oligonucleotide Synthesis Service Industry Restraints Table 5. Global DNA Oligonucleotide Synthesis Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global DNA Oligonucleotide Synthesis Service Revenue Share by Company (2021-2026) Table 7. Global DNA Oligonucleotide Synthesis Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global DNA Oligonucleotide Synthesis Service Key Company Manufacturing Base & Headquarters Table 9. Global DNA Oligonucleotide Synthesis Service Company, Product Type & Application Table 10. Global DNA Oligonucleotide Synthesis Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global DNA Oligonucleotide Synthesis Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Standard Oligonucleotides Table 15. Significant Companies of Micro-Oligonucleotides Table 16. Significant Companies of Large-scale Oligonucleotides Table 17. Significant Companies of Degenerate Primers Table 18. Significant Companies of Long Oligos Synthesis Table 19. Global DNA Oligonucleotide Synthesis Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global DNA Oligonucleotide Synthesis Service Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global DNA Oligonucleotide Synthesis Service Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global DNA Oligonucleotide Synthesis Service Sales Value Share by Type (2021-2026) Table 23. Global DNA Oligonucleotide Synthesis Service Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Commercial Table 25. Significant Companies of Academic Research Table 26. Global DNA Oligonucleotide Synthesis Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global DNA Oligonucleotide Synthesis Service Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global DNA Oligonucleotide Synthesis Service Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global DNA Oligonucleotide Synthesis Service Sales Value Share by Application (2021-2026) Table 30. Global DNA Oligonucleotide Synthesis Service Sales Value Share by Application (2027-2032) Table 31. Global DNA Oligonucleotide Synthesis Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global DNA Oligonucleotide Synthesis Service Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global DNA Oligonucleotide Synthesis Service Sales Value Share by Region (2021-2026) Table 34. Global DNA Oligonucleotide Synthesis Service Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global DNA Oligonucleotide Synthesis Service Sales Value Share by Region (2027-2032) Table 36. Global DNA Oligonucleotide Synthesis Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global DNA Oligonucleotide Synthesis Service Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global DNA Oligonucleotide Synthesis Service Sales Value Market Share by Country (2021-2026) Table 39. Global DNA Oligonucleotide Synthesis Service Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global DNA Oligonucleotide Synthesis Service Sales Value Market Share by Country (2027-2032) Table 41. Genewiz Company Information Table 42. Genewiz Business Overview Table 43. Genewiz DNA Oligonucleotide Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Genewiz DNA Oligonucleotide Synthesis Service Product Portfolio Table 45. Genewiz Recent Development Table 46. Eurofins Genomics Company Information Table 47. Eurofins Genomics Business Overview Table 48. Eurofins Genomics DNA Oligonucleotide Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Eurofins Genomics DNA Oligonucleotide Synthesis Service Product Portfolio Table 50. Eurofins Genomics Recent Development Table 51. Gene Oracle Company Information Table 52. Gene Oracle Business Overview Table 53. Gene Oracle DNA Oligonucleotide Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Gene Oracle DNA Oligonucleotide Synthesis Service Product Portfolio Table 55. Gene Oracle Recent Development Table 56. SBS Genetech Company Information Table 57. SBS Genetech Business Overview Table 58. SBS Genetech DNA Oligonucleotide Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. SBS Genetech DNA Oligonucleotide Synthesis Service Product Portfolio Table 60. SBS Genetech Recent Development Table 61. Creative Biolabs Company Information Table 62. Creative Biolabs Business Overview Table 63. Creative Biolabs DNA Oligonucleotide Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Creative Biolabs DNA Oligonucleotide Synthesis Service Product Portfolio Table 65. Creative Biolabs Recent Development Table 66. Bio Basic Company Information Table 67. Bio Basic Business Overview Table 68. Bio Basic DNA Oligonucleotide Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Bio Basic DNA Oligonucleotide Synthesis Service Product Portfolio Table 70. Bio Basic Recent Development Table 71. Kaneka Eurogentec SA Company Information Table 72. Kaneka Eurogentec SA Business Overview Table 73. Kaneka Eurogentec SA DNA Oligonucleotide Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Kaneka Eurogentec SA DNA Oligonucleotide Synthesis Service Product Portfolio Table 75. Kaneka Eurogentec SA Recent Development Table 76. AltaBioscience Company Information Table 77. AltaBioscience Business Overview Table 78. AltaBioscience DNA Oligonucleotide Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. AltaBioscience DNA Oligonucleotide Synthesis Service Product Portfolio Table 80. AltaBioscience Recent Development Table 81. Synbio Technologies Company Information Table 82. Synbio Technologies Business Overview Table 83. Synbio Technologies DNA Oligonucleotide Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Synbio Technologies DNA Oligonucleotide Synthesis Service Product Portfolio Table 85. Synbio Technologies Recent Development Table 86. TriLink Company Information Table 87. TriLink Business Overview Table 88. TriLink DNA Oligonucleotide Synthesis Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. TriLink DNA Oligonucleotide Synthesis Service Product Portfolio Table 90. TriLink Recent Development Table 91. Azenta Life Science Company Information Table 92. Azenta Life Science Business Overview Table 93. Azenta Life Science DNA Oligonucleotide Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Azenta Life Science DNA Oligonucleotide Synthesis Service Product Portfolio Table 95. Azenta Life Science Recent Development Table 96. KareBay Biochem Company Information Table 97. KareBay Biochem Business Overview Table 98. KareBay Biochem DNA Oligonucleotide Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. KareBay Biochem DNA Oligonucleotide Synthesis Service Product Portfolio Table 100. KareBay Biochem Recent Development Table 101. Creative Biogene Company Information Table 102. Creative Biogene Business Overview Table 103. Creative Biogene DNA Oligonucleotide Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Creative Biogene DNA Oligonucleotide Synthesis Service Product Portfolio Table 105. Creative Biogene Recent Development Table 106. Generi Biotech Company Information Table 107. Generi Biotech Business Overview Table 108. Generi Biotech DNA Oligonucleotide Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Generi Biotech DNA Oligonucleotide Synthesis Service Product Portfolio Table 110. Generi Biotech Recent Development Table 111. Primetech Company Information Table 112. Primetech Business Overview Table 113. Primetech DNA Oligonucleotide Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Primetech DNA Oligonucleotide Synthesis Service Product Portfolio Table 115. Primetech Recent Development Table 116. General Biosystems Company Information Table 117. General Biosystems Business Overview Table 118. General Biosystems DNA Oligonucleotide Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. General Biosystems DNA Oligonucleotide Synthesis Service Product Portfolio Table 120. General Biosystems Recent Development Table 121. GenScript Company Information Table 122. GenScript Business Overview Table 123. GenScript DNA Oligonucleotide Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. GenScript DNA Oligonucleotide Synthesis Service Product Portfolio Table 125. GenScript Recent Development Table 126. OriGene Company Information Table 127. OriGene Business Overview Table 128. OriGene DNA Oligonucleotide Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. OriGene DNA Oligonucleotide Synthesis Service Product Portfolio Table 130. OriGene Recent Development Table 131. BBI Company Information Table 132. BBI Business Overview Table 133. BBI DNA Oligonucleotide Synthesis Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. BBI DNA Oligonucleotide Synthesis Service Product Portfolio Table 135. BBI Recent Development Table 136. Research Programs/Design for This Report Table 137. Authors List of This Report Table 138. Secondary Sources Table 139. Primary Sources List of Figures Figure 1. DNA Oligonucleotide Synthesis Service Product Image Figure 2. Global DNA Oligonucleotide Synthesis Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DNA Oligonucleotide Synthesis Service Market Size (2021-2032) & (US$ Million) Figure 4. Global DNA Oligonucleotide Synthesis Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Standard Oligonucleotides Image Figure 8. Micro-Oligonucleotides Image Figure 9. Large-scale Oligonucleotides Image Figure 10. Degenerate Primers Image Figure 11. Long Oligos Synthesis Image Figure 12. Global DNA Oligonucleotide Synthesis Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global DNA Oligonucleotide Synthesis Service Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global DNA Oligonucleotide Synthesis Service Sales Value Share by Type (2021-2032) Figure 15. Commercial Image Figure 16. Academic Research Image Figure 17. Global DNA Oligonucleotide Synthesis Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global DNA Oligonucleotide Synthesis Service Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global DNA Oligonucleotide Synthesis Service Sales Value Share by Application (2021-2032) Figure 20. Global DNA Oligonucleotide Synthesis Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global DNA Oligonucleotide Synthesis Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America DNA Oligonucleotide Synthesis Service Sales Value (2021-2032) & (US$ Million) Figure 23. North America DNA Oligonucleotide Synthesis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe DNA Oligonucleotide Synthesis Service Sales Value (2021-2032) & (US$ Million) Figure 25. Europe DNA Oligonucleotide Synthesis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific DNA Oligonucleotide Synthesis Service Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific DNA Oligonucleotide Synthesis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America DNA Oligonucleotide Synthesis Service Sales Value (2021-2032) & (US$ Million) Figure 29. South America DNA Oligonucleotide Synthesis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa DNA Oligonucleotide Synthesis Service Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa DNA Oligonucleotide Synthesis Service Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Standard Oligonucleotides
  • Micro-Oligonucleotides
  • Large-scale Oligonucleotides
  • Degenerate Primers
  • Long Oligos Synthesis
Applications
  • Commercial
  • Academic Research
Companies covered
  • Genewiz
  • Eurofins Genomics
  • Gene Oracle
  • SBS Genetech
  • Creative Biolabs
  • Bio Basic
  • Kaneka Eurogentec SA
  • AltaBioscience
  • Synbio Technologies
  • TriLink
  • Azenta Life Science
  • KareBay Biochem
  • Creative Biogene
  • Generi Biotech
  • Primetech
  • General Biosystems
  • GenScript
  • OriGene
  • BBI

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global DNA Oligonucleotide Synthesis Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global DNA Oligonucleotide Synthesis Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 DNA Oligonucleotide Synthesis Service Market Dynamics
  1. 2.1 DNA Oligonucleotide Synthesis Service Industry Trends
  2. 2.2 DNA Oligonucleotide Synthesis Service Industry Drivers
  3. 2.3 DNA Oligonucleotide Synthesis Service Industry Opportunities and Challenges
  4. 2.4 DNA Oligonucleotide Synthesis Service Industry Restraints
3 DNA Oligonucleotide Synthesis Service Market by Company
  1. 3.1 Global DNA Oligonucleotide Synthesis Service Company Revenue Ranking in 2025
  2. 3.2 Global DNA Oligonucleotide Synthesis Service Revenue by Company (2021-2026)
  3. 3.3 Global DNA Oligonucleotide Synthesis Service Company Ranking (2024-2026)
  4. 3.4 Global DNA Oligonucleotide Synthesis Service Company Manufacturing Base and Headquarters
  5. 3.5 Global DNA Oligonucleotide Synthesis Service Company Product Type and Application
  6. 3.6 Global DNA Oligonucleotide Synthesis Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global DNA Oligonucleotide Synthesis Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 DNA Oligonucleotide Synthesis Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 DNA Oligonucleotide Synthesis Service Market by Type
  1. 4.1 DNA Oligonucleotide Synthesis Service Type Introduction
  2. 4.1.1 Standard Oligonucleotides
  3. 4.1.2 Micro-Oligonucleotides
  4. 4.1.3 Large-scale Oligonucleotides
  5. 4.1.4 Degenerate Primers
  6. 4.1.5 Long Oligos Synthesis
  7. 4.2 Global DNA Oligonucleotide Synthesis Service Sales Value by Type
  8. 4.2.1 Global DNA Oligonucleotide Synthesis Service Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global DNA Oligonucleotide Synthesis Service Sales Value by Type (2021-2032)
  10. 4.2.3 Global DNA Oligonucleotide Synthesis Service Sales Value Share by Type (2021-2032)
5 DNA Oligonucleotide Synthesis Service Market by Application
  1. 5.1 DNA Oligonucleotide Synthesis Service Application Introduction
  2. 5.1.1 Commercial
  3. 5.1.2 Academic Research
  4. 5.2 Global DNA Oligonucleotide Synthesis Service Sales Value by Application
  5. 5.2.1 Global DNA Oligonucleotide Synthesis Service Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global DNA Oligonucleotide Synthesis Service Sales Value by Application (2021-2032)
  7. 5.2.3 Global DNA Oligonucleotide Synthesis Service Sales Value Share by Application (2021-2032)
6 DNA Oligonucleotide Synthesis Service Regional Value Analysis
  1. 6.1 Global DNA Oligonucleotide Synthesis Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global DNA Oligonucleotide Synthesis Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global DNA Oligonucleotide Synthesis Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global DNA Oligonucleotide Synthesis Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America DNA Oligonucleotide Synthesis Service Sales Value (2021-2032)
  7. 6.3.2 North America DNA Oligonucleotide Synthesis Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe DNA Oligonucleotide Synthesis Service Sales Value (2021-2032)
  10. 6.4.2 Europe DNA Oligonucleotide Synthesis Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific DNA Oligonucleotide Synthesis Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific DNA Oligonucleotide Synthesis Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America DNA Oligonucleotide Synthesis Service Sales Value (2021-2032)
  16. 6.6.2 South America DNA Oligonucleotide Synthesis Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa DNA Oligonucleotide Synthesis Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa DNA Oligonucleotide Synthesis Service Sales Value Share by Country, 2025 VS 2032
7 DNA Oligonucleotide Synthesis Service Country-level Value Analysis
  1. 7.1 Global DNA Oligonucleotide Synthesis Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global DNA Oligonucleotide Synthesis Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global DNA Oligonucleotide Synthesis Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global DNA Oligonucleotide Synthesis Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt DNA Oligonucleotide Synthesis Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt DNA Oligonucleotide Synthesis Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt DNA Oligonucleotide Synthesis Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Genewiz
  2. 8.1.1 Genewiz Company Information
  3. 8.1.2 Genewiz Business Overview
  4. 8.1.3 Genewiz DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Genewiz DNA Oligonucleotide Synthesis Service Product Portfolio
  6. 8.1.5 Genewiz Recent Developments
  7. 8.2 Eurofins Genomics
  8. 8.2.1 Eurofins Genomics Company Information
  9. 8.2.2 Eurofins Genomics Business Overview
  10. 8.2.3 Eurofins Genomics DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eurofins Genomics DNA Oligonucleotide Synthesis Service Product Portfolio
  12. 8.2.5 Eurofins Genomics Recent Developments
  13. 8.3 Gene Oracle
  14. 8.3.1 Gene Oracle Company Information
  15. 8.3.2 Gene Oracle Business Overview
  16. 8.3.3 Gene Oracle DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Gene Oracle DNA Oligonucleotide Synthesis Service Product Portfolio
  18. 8.3.5 Gene Oracle Recent Developments
  19. 8.4 SBS Genetech
  20. 8.4.1 SBS Genetech Company Information
  21. 8.4.2 SBS Genetech Business Overview
  22. 8.4.3 SBS Genetech DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 SBS Genetech DNA Oligonucleotide Synthesis Service Product Portfolio
  24. 8.4.5 SBS Genetech Recent Developments
  25. 8.5 Creative Biolabs
  26. 8.5.1 Creative Biolabs Company Information
  27. 8.5.2 Creative Biolabs Business Overview
  28. 8.5.3 Creative Biolabs DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Creative Biolabs DNA Oligonucleotide Synthesis Service Product Portfolio
  30. 8.5.5 Creative Biolabs Recent Developments
  31. 8.6 Bio Basic
  32. 8.6.1 Bio Basic Company Information
  33. 8.6.2 Bio Basic Business Overview
  34. 8.6.3 Bio Basic DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bio Basic DNA Oligonucleotide Synthesis Service Product Portfolio
  36. 8.6.5 Bio Basic Recent Developments
  37. 8.7 Kaneka Eurogentec SA
  38. 8.7.1 Kaneka Eurogentec SA Company Information
  39. 8.7.2 Kaneka Eurogentec SA Business Overview
  40. 8.7.3 Kaneka Eurogentec SA DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kaneka Eurogentec SA DNA Oligonucleotide Synthesis Service Product Portfolio
  42. 8.7.5 Kaneka Eurogentec SA Recent Developments
  43. 8.8 AltaBioscience
  44. 8.8.1 AltaBioscience Company Information
  45. 8.8.2 AltaBioscience Business Overview
  46. 8.8.3 AltaBioscience DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 AltaBioscience DNA Oligonucleotide Synthesis Service Product Portfolio
  48. 8.8.5 AltaBioscience Recent Developments
  49. 8.9 Synbio Technologies
  50. 8.9.1 Synbio Technologies Company Information
  51. 8.9.2 Synbio Technologies Business Overview
  52. 8.9.3 Synbio Technologies DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Synbio Technologies DNA Oligonucleotide Synthesis Service Product Portfolio
  54. 8.9.5 Synbio Technologies Recent Developments
  55. 8.10 TriLink
  56. 8.10.1 TriLink Company Information
  57. 8.10.2 TriLink Business Overview
  58. 8.10.3 TriLink DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 TriLink DNA Oligonucleotide Synthesis Service Product Portfolio
  60. 8.10.5 TriLink Recent Developments
  61. 8.11 Azenta Life Science
  62. 8.11.1 Azenta Life Science Company Information
  63. 8.11.2 Azenta Life Science Business Overview
  64. 8.11.3 Azenta Life Science DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Azenta Life Science DNA Oligonucleotide Synthesis Service Product Portfolio
  66. 8.11.5 Azenta Life Science Recent Developments
  67. 8.12 KareBay Biochem
  68. 8.12.1 KareBay Biochem Company Information
  69. 8.12.2 KareBay Biochem Business Overview
  70. 8.12.3 KareBay Biochem DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 KareBay Biochem DNA Oligonucleotide Synthesis Service Product Portfolio
  72. 8.12.5 KareBay Biochem Recent Developments
  73. 8.13 Creative Biogene
  74. 8.13.1 Creative Biogene Company Information
  75. 8.13.2 Creative Biogene Business Overview
  76. 8.13.3 Creative Biogene DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Creative Biogene DNA Oligonucleotide Synthesis Service Product Portfolio
  78. 8.13.5 Creative Biogene Recent Developments
  79. 8.14 Generi Biotech
  80. 8.14.1 Generi Biotech Company Information
  81. 8.14.2 Generi Biotech Business Overview
  82. 8.14.3 Generi Biotech DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Generi Biotech DNA Oligonucleotide Synthesis Service Product Portfolio
  84. 8.14.5 Generi Biotech Recent Developments
  85. 8.15 Primetech
  86. 8.15.1 Primetech Company Information
  87. 8.15.2 Primetech Business Overview
  88. 8.15.3 Primetech DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Primetech DNA Oligonucleotide Synthesis Service Product Portfolio
  90. 8.15.5 Primetech Recent Developments
  91. 8.16 General Biosystems
  92. 8.16.1 General Biosystems Company Information
  93. 8.16.2 General Biosystems Business Overview
  94. 8.16.3 General Biosystems DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 General Biosystems DNA Oligonucleotide Synthesis Service Product Portfolio
  96. 8.16.5 General Biosystems Recent Developments
  97. 8.17 GenScript
  98. 8.17.1 GenScript Company Information
  99. 8.17.2 GenScript Business Overview
  100. 8.17.3 GenScript DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 GenScript DNA Oligonucleotide Synthesis Service Product Portfolio
  102. 8.17.5 GenScript Recent Developments
  103. 8.18 OriGene
  104. 8.18.1 OriGene Company Information
  105. 8.18.2 OriGene Business Overview
  106. 8.18.3 OriGene DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 OriGene DNA Oligonucleotide Synthesis Service Product Portfolio
  108. 8.18.5 OriGene Recent Developments
  109. 8.19 BBI
  110. 8.19.1 BBI Company Information
  111. 8.19.2 BBI Business Overview
  112. 8.19.3 BBI DNA Oligonucleotide Synthesis Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 BBI DNA Oligonucleotide Synthesis Service Product Portfolio
  114. 8.19.5 BBI Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst